Cleared Traditional

K071461 - MODEL 300D HOME OXYGEN LIQUEFIER

K071461 is an FDA 510(k) clearance for MODEL 300D HOME OXYGEN LIQUEFIER, manufactured by Copd Partners, Inc.. The device is a Class 2 Anesthesiology device with product code CAW cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K071461 · Copd Partners, Inc. · Anesthesiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2007
Decision
88d
Days
Class 2
Risk

K071461 is an FDA 510(k) clearance for the MODEL 300D HOME OXYGEN LIQUEFIER. Classified as Generator, Oxygen, Portable within the CAW classification (a category for home-use oxygen therapy and respiratory devices), Class II - Special Controls.

Submitted by Copd Partners, Inc. (Bonita Springs, US). The FDA issued a Cleared decision on August 21, 2007 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5440 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K071461

510(k) Number K071461 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 25, 2007
Decision Date August 21, 2007
Days to Decision 88 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 140d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAW Device Classification - Class 2, Special Controls

Product Code CAW Generator, Oxygen, Portable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAW Generator, Oxygen, Portable

All 224
Devices cleared under the same product code (CAW) and FDA review panel - the closest regulatory comparables to K071461.
THE INVACARE FLYER, MODEL IPC 100
K071928 · Invacare Corp. · Dec 2007
DEPLOYABLE OXYGEN GENERATION SYSTEM - MEDIUM (DOGS-M)
K071904 · Carleton Life Support Systems, Inc. · Oct 2007
DEVILBISS 5 LITER COMPACT OXYGEN CONCENTRATOR, MODEL 525 SERIES
K071397 · Sunrise Medical · Oct 2007
POGS, MODEL 33C
K063454 · On Site Gas Systems, Inc. · May 2007
EXPEDITIONARY DELPLOYABLE OXYGEN CONCENTRATION SYSTEM (EDOCS), MODELS 120B AND 30
K061414 · Pacific Consolidated Industries, LLC · Jan 2007
PORTABLE OXYGEN GENERATOR SYSTEM
K062153 · Molecular Products , Ltd. · Nov 2006